Ferritin levels in critically ill patients with COVID-19: A marker of outcome?
Open Access
- 3 June 2021
- journal article
- letter
- Published by E.U. European Publishing in Pneumon
- Vol. 34 (2), 1-5
- https://doi.org/10.18332/pne/135958
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19International Journal of Hematology, 2020
- Is the HScore useful in COVID-19?The Lancet, 2020
- Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different originRMD Open, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Clinical observation and management of COVID-19 patientsEmerging Microbes & Infections, 2020
- Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic SyndromeArthritis & Rheumatology, 2014
- HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 2006